Active

TRAK 1 ONCOLOGY VENTURES

Switched

BE0705826933

Rechtspersoon Besloten Vennootschap 1 establishment

Active for

7 year, 7 months

Registered office

Torenlei 2

2950 Kapellen

België

Names & denominations

TRAK 1 ONCOLOGY VENTURES

Official name

NL

Enterprise details

Enterprise type

Rechtspersoon

Legal form

Besloten Vennootschap

Legal situation

Normale toestand

Start date

26 September 2018

Contact

Not specified

Peppol

Active
0208:0705826933

Active since 2 Dec 2025

Powered by

Databakkes.be

Company info. No nonsense.

Activities

NACE-BEL activity descriptions are currently shown in Dutch. English translations are underway.

NACE-BEL activities

What does this company officially do?

82990 Main activity

Overige zakelijke dienstverlening, neg

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

What are NACE codes? NACE-BEL is the Belgian version of the European activity nomenclature. Each company has at least one code indicating its main activity.

Establishments

Establishment units

Physical locations of this company

Registered office

Torenlei 2

2950 Kapellen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Frequently asked questions

What is the enterprise number of TRAK 1 ONCOLOGY VENTURES?
The enterprise number of TRAK 1 ONCOLOGY VENTURES is BE0705826933.
What is the address of TRAK 1 ONCOLOGY VENTURES?
The registered office of TRAK 1 ONCOLOGY VENTURES is located at Torenlei 2, 2950 Kapellen.
When was TRAK 1 ONCOLOGY VENTURES founded?
TRAK 1 ONCOLOGY VENTURES was founded on 26 September 2018.
What is the main activity of TRAK 1 ONCOLOGY VENTURES?
The main activity of TRAK 1 ONCOLOGY VENTURES is "Overige zakelijke dienstverlening, neg" (NACE code 82990).
Does TRAK 1 ONCOLOGY VENTURES have a website?
No website is currently known for TRAK 1 ONCOLOGY VENTURES.